Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$673M |
| 2 |
Apple
AAPL
|
+$515M |
| 3 |
Linde
LIN
|
+$512M |
| 4 |
Walt Disney
DIS
|
+$502M |
| 5 |
Flutter Entertainment
FLUT
|
+$458M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum China
YUMC
|
+$514M |
| 2 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
+$465M |
| 3 |
Workday
WDAY
|
+$424M |
| 4 |
Synopsys
SNPS
|
+$408M |
| 5 |
Adobe
ADBE
|
+$396M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.56% |
| 2 | Financials | 12.21% |
| 3 | Industrials | 11.9% |
| 4 | Healthcare | 11.02% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Xeris Biopharma Holdings
XERS
$1.51B
| $141K | ﹤0.01% |
63,802
+625
| +1% | +$1.62K |
|
|
INZY
3602
DELISTED
Inozyme Pharma
INZY
| $141K | ﹤0.01% |
18,384
+541
| +3% | +$2.97K |
|
|
OPTU
3603
Optimum Communications Inc
OPTU
$312M
| $141K | ﹤0.01% |
53,898
+14,743
| +38% | +$37.1K |
|
3604
CorMedix
CRMD
$573M
| $140K | ﹤0.01% |
32,941
+3,516
| +12% | +$12.2K |
|
3605
Westrock Coffee
WEST
$814M
| $138K | ﹤0.01% |
13,386
-147
| -1% | -$1.48K |
|
3606
X4 Pharmaceuticals
XFOR
$434M
| $137K | ﹤0.01% |
3,287
+73
| +2% | +$2.03K |
|
|
SNPO
3607
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $137K | ﹤0.01% |
+15,876
| New | +$131K |
|
3608
Axogen
AXGN
$2.58B
| $135K | ﹤0.01% |
16,759
-1,047
| -6% | -$9.38K |
|
|
YSG
3609
Yatsen Holding
YSG
$309M
| $134K | ﹤0.01% |
63,317
+2,476
| +4% | +$7.34K |
|
|
DAO
3610
Youdao
DAO
$2.21B
| $133K | ﹤0.01% |
33,193
+1,510
| +5% | +$5.83K |
|
3611
Nano X Imaging
NNOX
$74.5M
| $132K | ﹤0.01% |
13,502
-2,264
| -14% | -$18.1K |
|
3612
Heron Therapeutics
HRTX
$60.6M
| $131K | ﹤0.01% |
47,148
-10,164
| -18% | -$25.5K |
|
3613
Finance of America Companies
FOA
$196M
| $129K | ﹤0.01% |
17,502
+16,370
| +1,446% | +$142K |
|
3614
Rigel Pharmaceuticals
RIGL
$778M
| $127K | ﹤0.01% |
8,550
+103
| +1% | +$1.39K |
|
3615
Omeros
OMER
$984M
| $127K | ﹤0.01% |
36,669
-5,721
| -13% | -$21.8K |
|
|
RAPT
3616
DELISTED
RAPT Therapeutics
RAPT
| $121K | ﹤0.01% |
1,691
-6,454
| -79% | -$897K |
|
3617
Lexicon Pharmaceuticals
LXRX
$1.05B
| $120K | ﹤0.01% |
49,818
-11,364
| -19% | -$24.4K |
|
3618
NextDecade
NEXT
$1.8B
| $119K | ﹤0.01% |
20,922
-985
| -4% | -$4.92K |
|
|
ELP
3619
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $115K | ﹤0.01% |
14,908
+2,965
| +25% | +$24.1K |
|
3620
MeiraGTx Holdings
MGTX
$1.2B
| $114K | ﹤0.01% |
18,793
+1,080
| +6% | +$6.82K |
|
3621
Lindblad Expeditions
LIND
$2.13B
| $114K | ﹤0.01% |
12,206
-553
| -4% | -$5.09K |
|
3622
Coherus Oncology
CHRS
$182M
| $113K | ﹤0.01% |
47,313
-84
| -0.2% | -$207 |
|
|
LUNA
3623
DELISTED
Luna Innovations Incorporated
LUNA
| $112K | ﹤0.01% |
35,049
+15,982
| +84% | +$102K |
|
3624
Pulmonx
LUNG
$98.4M
| $108K | ﹤0.01% |
11,665
-13,973
| -55% | -$164K |
|
|
BLUE
3625
DELISTED
bluebird bio
BLUE
| $105K | ﹤0.01% |
4,089
-672
| -14% | -$17.2K |
|
Similar funds
Invesco's Q1 2024 Portfolio in Review
As of Q1 2024, Invesco held 4,000 positions worth $466B, up 11% from $420B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Invesco's Q1 2024 filing shows 185 new, 2,081 increased, 1,463 reduced and 143 closed positions. Its largest new stake was Flutter Entertainment: 2,145,165 shares worth $424M. The largest sale was Yum China, an estimated $514M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q1 2024 buy was Flutter Entertainment: 2,145,165 shares worth $424M.
- Invesco added most to Microsoft in Q1 2024, an estimated $673M increase.
- Invesco's biggest Q1 2024 reduction was Yum China, cutting an estimated $514M.
- Invesco fully exited Invesco S&P 500 Pure Growth ETF in Q1 2024, selling an estimated $251M.
- Invesco's ten largest holdings make up 16% of its $466B portfolio in Q1 2024.
- Invesco opened 185 new positions and closed 143 in Q1 2024.
- Invesco's portfolio value rose 11% quarter-over-quarter to $466B.
Based on Invesco's 13F filing for Q1 2024, filed 14 May 2024.